Adrian Adams

Shares of Aralez Pharmaceuticals Inc (NASDAQ: ARLZ) were volatile on Monday after the company announced the U.S. Food and Drug Administration accepted the company's New Drug Application for its investigational candidate, YOSPRALA. Shares of Aralez opened for trading at $3.73 and spiked to...

Collins Stewart released a report concerning Auxilium Pharmaceuticals' (NASDAQ: AUXL) CEO putting focus on execution in only his fourth week on the job. “[Adrian] Adams is focused on the following: 1) the commercial execution of Testim and Xiaflex; 2) advancing new indications for Xiaflex,...